Design and Evaluation of Self-nanoemulsifying Pellets of Repaglinide

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2013 Jun 19

PMID 23775389

Citations 7

Authors

N S Desai

M S Nagarsenker

Affiliations

Soon will be listed here.

Abstract

The aim of study was to develop self-nanoemulsifying pellets (SNEP) for oral delivery of poorly water soluble drug, repaglinide (RPG). Solubility of RPG in oily phases and surfactants was determined to identify components of self-nanoemulsifying drug delivery system (SNEDDS). The surfactants and cosurfactants were screened for their ability to emulsify oily phase. Ternary phase diagrams were constructed to identify nanoemulsification area for the selected systems. SNEDDS formulations with globule size less than 100 nm were evaluated for in vivo anti-hyperglycemic activity in neonatal streptozotocin rat model. A significant reduction in glucose levels was produced by optimized SNEDDS formulation in comparison to the control group. The optimized SNEDDS formulations were pelletized via extrusion/spheronization technique using microcrystalline cellulose and lactose. SNEP were characterized by X-ray powder diffraction and scanning electron microscopy. X-ray diffraction study indicated loss of crystallinity of RPG in SNEP. The SNEP exhibited good flow properties, mechanical strength and formed nanoemulsion with globule size less than 200 nm. SNEP showed in vitro release of more than 80% RPG in 10 min which was significantly higher than RPG containing reference pellets. In conclusion, our studies illustrated that RPG, a poorly water soluble drug can be successfully formulated into SNEP which can serve as a promising system for the delivery of poorly water soluble drugs.

Citing Articles

Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.

Preeti , Sambhakar S, Saharan R, Narwal S, Malik R, Gahlot V Saudi Pharm J. 2023; 31(12):101870.

PMID: 38053738 PMC: 10694332. DOI: 10.1016/j.jsps.2023.101870.

Multivariate Data Analysis and Central Composite Design-Oriented Optimization of Solid Carriers for Formulation of Curcumin-Loaded Solid SNEDDS: Dissolution and Bioavailability Assessment.

Corrie L, Kaur J, Awasthi A, Vishwas S, Gulati M, Saini S Pharmaceutics. 2022; 14(11).

PMID: 36365213 PMC: 9697677. DOI: 10.3390/pharmaceutics14112395.

Solidification of Self-Emulsifying Drug Delivery Systems as a Novel Approach to the Management of Uncomplicated Malaria.

Seo E, du Plessis L, Viljoen J Pharmaceuticals (Basel). 2022; 15(2).

PMID: 35215233 PMC: 8877057. DOI: 10.3390/ph15020120.

Development, Characterization, and in-vivo Pharmacokinetic Study of Lamotrigine Solid Self-Nanoemulsifying Drug Delivery System.

Abdelmonem R, Azer M, Makky A, Zaghloul A, El-Nabarawi M, Nada A Drug Des Devel Ther. 2020; 14:4343-4362.

PMID: 33116420 PMC: 7585523. DOI: 10.2147/DDDT.S263898.

Formulation and Pharmacokinetic Evaluation of Phosal Based Zaltoprofen Solid Self-Nanoemulsifying Drug Delivery System.

Kalamkar R, Wadher S Pharm Nanotechnol. 2019; 7(4):328-338.

PMID: 31376828 PMC: 7040505. DOI: 10.2174/2211738507666190802141754.

References

Pouton C, Porter C . Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2007; 60(6):625-37. DOI: 10.1016/j.addr.2007.10.010. View

Mahmoud E, Bendas E, Mohamed M . Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS PharmSciTech. 2009; 10(1):183-92. PMC: 2663682. DOI: 10.1208/s12249-009-9192-7. View

Wu W, Wang Y, Que L . Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006; 63(3):288-94. DOI: 10.1016/j.ejpb.2005.12.005. View

Zawar L, Bari S . Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion. Chem Pharm Bull (Tokyo). 2012; 60(4):482-7. DOI: 10.1248/cpb.60.482. View

Balakrishnan P, Lee B, Oh D, Kim J, Hong M, Jee J . Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 2009; 72(3):539-45. DOI: 10.1016/j.ejpb.2009.03.001. View

Date A, Nagarsenker M . Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2006; 329(1-2):166-72. DOI: 10.1016/j.ijpharm.2006.08.038. View

Abdalla A, Mader K . Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm. 2007; 66(2):220-6. DOI: 10.1016/j.ejpb.2006.11.015. View

Lawrence M, Rees G . Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000; 45(1):89-121. DOI: 10.1016/s0169-409x(00)00103-4. View

Malaisse W . Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies. Eur J Clin Invest. 1999; 29 Suppl 2:21-9. DOI: 10.1046/j.1365-2362.1999.00001.x. View

10.

Hu X, Lin C, Chen D, Zhang J, Liu Z, Wu W . Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm. 2012; 438(1-2):123-33. DOI: 10.1016/j.ijpharm.2012.07.055. View

11.

Mandic Z, Gabelica V . Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal. 2006; 41(3):866-71. DOI: 10.1016/j.jpba.2006.01.056. View

12.

Gursoy R, Benita S . Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004; 58(3):173-82. DOI: 10.1016/j.biopha.2004.02.001. View

13.

Purvis T, Mattucci M, Crisp M, Johnston K, Williams 3rd R . Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS PharmSciTech. 2007; 8(3):E58. DOI: 10.1208/pt0803058. View

14.

Mei X, Etzler F, Wang Z . Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006; 324(2):128-35. DOI: 10.1016/j.ijpharm.2006.06.017. View

15.

Chang R, Raghavan K, Hussain M . A study on gelatin capsule brittleness: moisture tranfer between the capsule shell and its content. J Pharm Sci. 1998; 87(5):556-8. DOI: 10.1021/js9704238. View

16.

Newton J, Pinto M, Podczeck F . The preparation of pellets containing a surfactant or a mixture of mono- and di-gylcerides by extrusion/spheronization. Eur J Pharm Sci. 2007; 30(3-4):333-42. DOI: 10.1016/j.ejps.2006.11.020. View

17.

Culy C, Jarvis B . Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus. Drugs. 2001; 61(11):1625-60. DOI: 10.2165/00003495-200161110-00008. View

18.

Tuleu C, Newton M, Rose J, Euler D, Saklatvala R, Clarke A . Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004; 93(6):1495-502. DOI: 10.1002/jps.20068. View

19.

Dixit R, Nagarsenker M . Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm. 2008; 34(12):1285-96. DOI: 10.1080/03639040802071570. View

20.

Date A, Desai N, Dixit R, Nagarsenker M . Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond). 2010; 5(10):1595-616. DOI: 10.2217/nnm.10.126. View